Naturalendo Tech Co. Ltd. | Mutual Funds
Mutual Funds that own Naturalendo Tech Co. Ltd.
Vanguard Total International Stock Index Fund
194,233
0.94%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
155,603
0.75%
0
0.01%
09/05/2018
JPMorgan Funds - Korea Equity Fund
75,000
0.36%
6,500
0.55%
06/30/2018
Vanguard Developed Markets Index Fund
73,316
0.36%
0
0%
07/31/2018
JPMorgan Funds - Korea Fund
68,500
0.33%
68,500
0.55%
03/31/2018
Mirae Asset TIGER Health Care ETF
33,433
0.16%
8,556
0.44%
04/30/2018
Vanguard FTSE All World (ex-US) Small Cap
32,929
0.16%
0
0.01%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
28,921
0.14%
0
0.01%
09/05/2018
Vanguard Pacific Stock Index Fund
17,385
0.08%
0
0%
07/31/2018
SPDR S&P International Small Cap ETF
17,030
0.08%
0
0.04%
09/06/2018
| Address |
3/F, Building A CS Tower
Seongnam GY 13486
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.naturalendo.co.kr |
| Updated |
09/14/2018 |
| Naturalendo Tech Co., Ltd. engages in the physical, chemical, biological research and development of healthcare materials. The company engages in following business activities which include the research, development, manufacture and sale of health food materials, cosmetic materials and drug delivery system. It also offers hormone replacement therapy and non-hormone therapy for women. |
